While telehealth startups chase direct-to-consumer buzz, SteadyMD is building the critical infrastructure behind the scenes. They're not selling to patients—they're selling to founders who need to scale their clinical workforce without drowning in regulatory hell.

"SteadyMD isn't in the telehealth business—they're in the telehealth infrastructure business, and that's a far more defensible position."

The competitive landscape is telling. SteadyMD's top organic keyword isn't their own brand—it's 'openloop' (6,110 monthly searches). This reveals a market where customers are actively comparing solutions. They're not just capturing demand; they're competing head-to-head in a crowded space and holding their own.

• They've identified a $28.9M revenue opportunity in the unsexy infrastructure layer of telehealth
• Their 2.9/5 Trustpilot score from just 2 reviews suggests early-stage customer satisfaction challenges
• The 'steadymd trt' keyword (180 monthly searches) reveals they're serving the testosterone replacement therapy market—a high-margin niche
• Their traffic is 96.9% from 'undefined' countries, suggesting either tracking issues or a truly global, borderless customer base